Executive Summary
The Delhi High Court addressed a suit filed by Sun Pharmaceutical Industries Ltd. against M/S. Orison Pharmaceuticals concerning alleged trademark infringement and passing off of marks like 'REVITAL' and 'CEROXIM'. Despite the plaintiff alleging deceptive similarity in the defendant's marks ('ORIVITAL' and 'OXIM'), both parties expressed interest in exploring a settlement. Consequently, the Court referred the matter to the Delhi High Court Mediation and Conciliation Centre for resolution.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in trademark matters before Delhi High Court - Orders. Understanding the court's reasoning in Sun Pharmaceutical Industries Ltd. vs M/S. Orison Pharmaceuticals is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Microsoft CorporationvsPcpatchers Technology Private Limited
In a significant ruling concerning brand protection, the Delhi High Court directed various international Domain Name Registrars (DNRs) to comply with an existing injunction. Microsoft Corporation sought permanent relief against entities allegedly violating its trademarks and copyrights through fraudulent activities using 'MICROSOFT' in domain names. The court granted a final opportunity for DNRs to provide necessary WHOIS details and suspend the infringing domains, warning that failure to comply within one week would lead to legal action by the Ministry of Electronics and Information Technology (MeitY).
Gopal Engineering & Chemical Works Pvt LtdvsVikrant Chemico Industries Pvt Ltd
The Delhi High Court dismissed an appeal filed by Gopal Engineering & Chemical Works Pvt Ltd challenging a prior order that confirmed an ex parte interim injunction. The court upheld the injunction, finding that the respondent's registered trademark 'Doctor Brand Phenyle' had acquired distinctiveness and was associated with its phenyl disinfectant product. Despite the appellants' claims of rights via assignment deeds, the court found their use of 'Doctor Hazel' to be infringing, while allowing them to continue using 'Chemist brand germ troll.'
Hindustan Unilever Ltd.vsTuba Chemical Works
Hindustan Unilever Ltd. filed a Commercial IP Suit against Tuba Chemical Works alleging infringement and passing off related to its registered trademarks in Class 03. The Bombay High Court granted leave, decreed the suit, and issued permanent injunctions restraining the defendant from using similar logos or marks on detergent powder.
Latha C. MohanvsCavinkar Pvt. Ltd. And Ors.
The Madras High Court granted an interim injunction in favor of Latha C. Mohan, who claimed prior use and goodwill associated with her beauty parlour business under the trade name 'Kanya.' The court found that both parties operated within the same field (cosmetology/beauty), creating a likelihood of consumer confusion and diversion of trade. Despite the respondent's registered trademarks, the applicant successfully established a real and tangible risk of damage to her commercial reputation, warranting immediate protection.
Surge Biotech Pvt LtdvsSurge Pharmaceuticals Pvt Ltd
The Gujarat High Court disposed of an Appeal from Order in a trademark dispute between Surge Biotech Pvt Ltd and Surge Pharmaceuticals Pvt Ltd. Due to mutual consensus between both parties, the court quashed the previous order passed by the trial court regarding Exh.5 application. The case has been remanded back to the trial court to decide the matter afresh, ensuring both sides are given an opportunity to present their arguments.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.